Frank Pallone actually said...

I am amazed by how much variation exists in the care provided in the post-acute setting.

I do think that is important to have but, I mean, it is always going to be individual case too, though, obviously.

I would encourage them to do what they can to support that.

the purpose of the breakthrough therapy designation was to, as you say, Mr. Pallone, too, advance and give the flexibility for FDA to respon...